Skip to main content
. 2018 Oct 29;21(4):382–390. doi: 10.4048/jbc.2018.21.e48

Table 3. Multivariate analysis for disease-free survival.

graphic file with name jbc-21-382-i003.jpg

HR=hazard ratio; CI=confidence interval; HER2=human epidermal growth factor receptor 2; NAC=neoadjuvant chemotherapy; cN=clinical node; ypN=post-NAC pathologic node; LVI=lymphovascular invasion.

*HER2 enriched subgroup versus luminal B subgroup.